Search

Search Constraints

You searched for: Author/Creator Meng, Chengcheng

Search Results

1. Anti‐SARS‐CoV‐2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID‐19 therapy. Issue 1 (28th September 2022)

2. Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU‐285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies. (15th July 2019)

4. Effects of the multi‐kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia. Issue 5 (22nd January 2020)

8. The cancer-associated CTCFL/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements. Issue 1 (December 2016)

9. The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations. Issue 3 (14th January 2020)